Traditionally, world superpowers and space agencies have experimented with chemical synthesis in orbit. The results are far different from those obtained on Earth and often impossible to achieve under the effects of gravity.\u00a0 Now we are creatign a new Pharmaceutical laboratory in space. <\/p>\n\n\n\n
For companies such as Space Pharma<\/a>, life sciences in orbit or in microgravity are a not-so-distant revolution. They call it \u2018the fourth space revolution,\u2019 in which they seek to build remote-controlled miniaturized laboratories in satellites or space stations where they can produce molecules far superior to their equivalents on Eart<\/strong>h. The business model lies in the fact that these molecules are much more efficient. With just one gram of these space-produced substances, we can produce a kilogram of material on Earth, a 1,000 to 1 return on investment. <\/p>\n\n\n\n We need to ensure that we can implement those ideas and assess their potential turnover.<\/p>\n\n\n\n Conference by Yossi Yamin<\/a>, Chairman & R&D CEO at SpacePharma,<\/a> at the XXXI Future Trends Forum about the Commercialization of Space.<\/p>\n\n\n\n Yossi explains the benefits of microgravity in medical, pharmaceutical laboratory and biotechnology research.<\/p>\n\n\n\nA laboratory in the space for health on Earth<\/h2>\n\n\n\n